NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 64 filers reported holding NEOS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 3.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $118,000 | – | 16,195 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 693,582 | $4,057,000 | 2.30% |
| DAFNA Capital Management LLC | 38,873 | $227,000 | 0.20% |
| FALCON POINT CAPITAL, LLC | 85,588 | $501,000 | 0.07% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 229,166 | $1,341,000 | 0.06% |
| Cormorant Asset Management, LP | 50,613 | $296,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 14,587 | $85,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 80,000 | $468,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 296,175 | $1,733,000 | 0.00% |
| FRANKLIN RESOURCES INC | 1,315,500 | $7,696,000 | 0.00% |
| COLUMBUS CIRCLE INVESTORS | 42,304 | $247,000 | 0.00% |